Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors

Mostrar otras versiones (1)

There is an urgent need for vaccines and antiviral drugs to combat the COVID-19 pandemic. Encouraging progress has been made in developing antivirals targeting SARS-CoV-2, the etiological agent of COVID-19. Among the drug targets being investigated, the viral main protease (M(pro)) is one of the mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chunlong, Hu, Yanmei, Townsend, Julia Alma, Lagarias, Panagiotis I., Marty, Michael Thomas, Kolocouris, Antonios, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523112/
https://www.ncbi.nlm.nih.gov/pubmed/32995786
http://dx.doi.org/10.1101/2020.09.15.299164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523112/
https://www.ncbi.nlm.nih.gov/pubmed/32995786
http://dx.doi.org/10.1101/2020.09.15.299164

Ejemplares similares